
Please try another search
Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabilities to connect trophon 2 with hospital IT systems; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Name | Age | Since | Title |
---|---|---|---|
Michael C. Kavanagh | - | 2012 | CEO, President, MD & Executive Director |
Steven Andrew Sargent | 62 | 2016 | Independent Chairman & Lead Independent Non-Executive Director |
Marie E. McDonald | 66 | 2016 | Independent Non-Executive Director |
Tracey Leigh Batten | 59 | 2023 | Non-Executive Director |
Gerard Dalbosco | 62 | 2025 | Independent Non-Executive Director |
Larry R. Marshall | - | 2023 | Non- Executive Director |
Lisa E. Margaret McIntyre | 60 | 2019 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review